查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1549486

全球抗体生产市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Antibody Production Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

全球抗体生产市场需求预计将从2023年的230.9亿美元达到2032年近714.9亿美元的市场规模，2024-2032年研究期间复合年增长率为13.38%。

抗体生产是一种生物技术过程，其中产生用于诊断、治疗或研究目的的特异性抗体。这涉及对动物进行免疫或使用细胞培养物来引发免疫反应，然后收穫免疫反应以获得针对特定抗原的抗体。这些抗体也称为免疫球蛋白，对于检测疾病、进行研究和开发标靶治疗至关重要。单株抗体技术等先进技术可以产生高度特异性的抗体，这对于推进医学科学和个人化医疗至关重要。

市场动态

感染、病毒以及癌症、类风湿和慢性病等其他疾病的盛行率不断上升是推动抗体生产市场成长的因素。医学研究中心对研发项目和新产品的技术进步的投资不断增加，预计将推动抗体生产的市场成长。许多药品正在转向生物製药，这可能会推动抗体生产的市场成长。此外，预计标靶治疗的日益使用将扩大抗体生产的整体市场成长。政府对抗体生产激励措施的增加预计将推动市场成长。相反，抗体生产的总体成本以及严格的政府批准疗法和药物的政策可能会进一步阻碍抗体生产的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球抗体生产市场的每个细分市场进行了包容性评估。抗体生产产业的成长和趋势为本研究提供了整体方法。

市场区隔

抗体生产市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

  • 仪器（生物反应器（多用途生物反应器、一次性生物反应器）、层析系统、过滤系统）
  • 消耗品（介质、缓衝液和试剂、色谱树脂和色谱柱、过滤消耗品和配件、其他）
  • 软体

按流程

  • 上游处理
  • 下游加工

按类型

  • 单株抗体
  • 多株抗体抗体

按最终用途

  • 製药和生物技术公司
  • 研究实验室
  • CRO 和 CDMO

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲抗体生产市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。抗体生产市场的主要参与者包括 Illumina Inc.、Thermo Fisher Scientific Inc.、Pacific Biosciences Of California Inc.、BGI、QIAGEN、Agilent Technologies、PerkinElmer Inc.、ProPhase Labs Inc.、Psomagen、Azenta US Inc.。竞争格局的整体看法，包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：抗体生产 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按流程进行市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球抗体生产市场分析：按产品

  • 概述（按产品）
  • 按产品分类的历史和预测资料分析
  • 仪器（生物反应器（多用途生物反应器、一次性生物反应器）、层析系统、过滤系统）
  • 消耗品（介质、缓衝液和试剂、色谱树脂和色谱柱、过滤消耗品和配件、其他）
  • 软体

第 6 章：全球抗体生产市场分析：依流程

  • 按流程概述
  • 按流程进行历史和预测资料分析
  • 上游处理
  • 下游加工

第 7 章：全球抗体生产市场分析：按类型

  • 按类型概述
  • 按类型分析历史和预测数据
  • 单株抗体
  • 多株抗体抗体

第 8 章：全球抗体生产市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 製药和生物技术公司
  • 研究实验室
  • CRO 和 CDMO

第 9 章：全球抗体生产市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：抗体生产公司的竞争格局

  • 抗体生产市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Illumina Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pacific Biosciences Of California Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BGI
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • QIAGEN
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Agilent Technologies
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PerkinElmer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • ProPhase Labs Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Psomagen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Azenta US Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112110211

The global demand for Antibody Production Market is presumed to reach the market size of nearly USD 71.49 Billion by 2032 from USD 23.09 Billion in 2023 with a CAGR of 13.38% under the study period 2024-2032.

Antibody production is a biotechnological process wherein specific antibodies are generated for diagnostic, therapeutic, or research purposes. This involves immunizing animals or using cell cultures to elicit an immune response, which is then harvested to obtain antibodies targeting particular antigens. These antibodies, also known as immunoglobulins, are pivotal in detecting diseases, conducting research, and developing targeted treatments. Advanced techniques such as monoclonal antibody technology allow for the creation of highly specific antibodies, which are critical in advancing medical science and personalized medicine.

MARKET DYNAMICS

The rising prevalence of infections, viruses, and other diseases like cancer, rheumatoid and chronic diseases are factors driving the market growth of antibody production. Growing investments by medical research centers for research and development projects and technological advancements for new launches are expected to propel the market growth of antibody production. Numerous pharmaceuticals are shifting towards biopharma which may drive the market growth of antibody production. Furthermore, the growing use of targeted therapies is anticipated to expand the overall market growth of antibody production. The rise in government incentives for antibody production is projected to drive market growth. On the contrary, the overall cost of antibody production and strict government policies for the approval of the therapies and drugs may further hamper the market growth of antibody production.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Antibody Production. The growth and trends of Antibody Production industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Antibody Production market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems)
  • Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others)
  • Software

By Process

  • Upstream Processing
  • Downstream Processing

By Type

  • Monoclonal Antibody
  • Polyclonal Antibody

By End-use

  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories
  • CROs and CDMOs

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antibody Production market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antibody Production market include Illumina Inc., Thermo Fisher Scientific Inc., Pacific Biosciences Of California Inc., BGI, QIAGEN, Agilent Technologies, PerkinElmer Inc., ProPhase Labs Inc., Psomagen, Azenta US Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ANTIBODY PRODUCTION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Process
    • 3.7.3 Market Attractiveness Analysis By Type
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems) Historic and Forecast Sales By Regions
  • 5.4. Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others) Historic and Forecast Sales By Regions
  • 5.5. Software Historic and Forecast Sales By Regions

6. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY PROCESS

  • 6.1. Overview By Process
  • 6.2. Historical and Forecast Data Analysis By Process
  • 6.3. Upstream Processing Historic and Forecast Sales By Regions
  • 6.4. Downstream Processing Historic and Forecast Sales By Regions

7. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY TYPE

  • 7.1. Overview By Type
  • 7.2. Historical and Forecast Data Analysis By Type
  • 7.3. Monoclonal Antibody Historic and Forecast Sales By Regions
  • 7.4. Polyclonal Antibody Historic and Forecast Sales By Regions

8. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data Analysis By End-use
  • 8.3. Pharmaceutical and Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.4. Research Laboratories Historic and Forecast Sales By Regions
  • 8.5. CROs and CDMOs Historic and Forecast Sales By Regions

9. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTIBODY PRODUCTION COMPANIES

  • 10.1. Antibody Production Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ANTIBODY PRODUCTION INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Illumina Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Thermo Fisher Scientific Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Pacific Biosciences Of California Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. BGI
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. QIAGEN
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Agilent Technologies
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. PerkinElmer Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. ProPhase Labs Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Psomagen
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Azenta US Inc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems) Market Sales By Geography (USD MN)
  • Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others) Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Analysis By Process (USD MN)
  • Upstream Processing Market Sales By Geography (USD MN)
  • Downstream Processing Market Sales By Geography (USD MN)
  • Analysis By Type (USD MN)
  • Monoclonal Antibody Market Sales By Geography (USD MN)
  • Polyclonal Antibody Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Pharmaceutical and Biotechnology Companies Market Sales By Geography (USD MN)
  • Research Laboratories Market Sales By Geography (USD MN)
  • CROs and CDMOs Market Sales By Geography (USD MN)
  • Global Antibody Production Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Antibody Production Report
  • Market Research Process
  • Market Research Methodology
  • Global Antibody Production Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Process
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems) Market Sales By Geography (USD MN)
  • Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others) Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Global Market Analysis By Process (USD MN)
  • Upstream Processing Market Sales By Geography (USD MN)
  • Downstream Processing Market Sales By Geography (USD MN)
  • Global Market Analysis By Type (USD MN)
  • Monoclonal Antibody Market Sales By Geography (USD MN)
  • Polyclonal Antibody Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Pharmaceutical and Biotechnology Companies Market Sales By Geography (USD MN)
  • Research Laboratories Market Sales By Geography (USD MN)
  • CROs and CDMOs Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.